988 Results

People

  1. Lesokhin
    Lesokhin
  2. Landgren
    Landgren
  3. Hassoun
    Hassoun
  4. Mailankody
    Mailankody
  5. Landau
    Landau
  6. Giralt
    Giralt
  7. Korde
    Korde
  8. Hultcrantz
    Hultcrantz
  9. Chung
    Chung
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)
  7. Sloan Kettering Institute Postdocs (292)
  8. Bone Marrow Transplant (289)
  9. Epidemiology and Biostatistics (209)
  10. Biostatistics Service (175)
  1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience
    Meeting Abstract

    Landau, H.; Hassoun, H.; Bello, C.; Chou, J.; Devlin, S.; Giralt, S. A.; Comenzo, R.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with systemic light chain amyloidosis (AL) treated at diagnosis with risk-adapted stem cell transplant and consolidation with novel agents
    Meeting Abstract

    Landau, H.; Fein, D.; Hassoun, H.; Bello, C.; Chou, J.; Devlin, S.; Giralt, S. A.; Comenzo, R.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
    Journal Article

    Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
    Journal Article

    Witzig, T. E.; Laumann, K. M.; Lacy, M. Q.; Hayman, S. R.; Dispenzieri, A.; Kumar, S.; Reeder, C. B.; Roy, V.; Lust, J. A.; Gertz, M. A.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pilot study of MAGE-A3 protein vaccination and autologous stem cell transplantation (autoSCT) as consolidation therapy for multiple myeloma (MM)
    Meeting Abstract

    Cohen, A. D.; Lendvai, N.; Gnjatic, S.; Jungbluth, A. A.; Pan, L. S.; Bertolini, S. V.; Venhaus, R. R.; Fellague-Chebra, R.; Gruselle, O.; Cho, H. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Blood (2012)

    Fulltext@MSK | Save
  • Early changes in cytokines, chemokines and indices of bone metabolism in a phase 2 study of the bruton tyrosine kinase (Btk) inhibitor, ibrutinib (PCI-32765) in patients with relapsed or relapsed/refractory multiple myeloma (MM)
    Meeting Abstract

    Vij, R.; Chang, B. Y.; Berdeja, J. G.; Huff, C. A.; Lendvai, N.; Tai, Y. T.; Chang, S.; Moussa, D.; Buggy, J. J.; Elias, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase II study of infusional carfilzomib in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Lendvai, N.; Landau, H.; Lesokhin, A.; Tsakos, I.; Koehne, G.; Chung, D.; Devlin, S.; Hassoun, H.; Giralt, S. A.
    Blood (2012)

    Fulltext@MSK | Save